טוען...
Treatment of Dysplasia in Barrett Esophagus
Barrett esophagus is recognized as a risk factor for the development of dysplasia and adenocarcinoma of the esophagus. Cancer is usually diagnosed at an advanced stage with a 5-year survival rate of 15%. Most of these patients present de novo and are not part of a surveillance program. Endoscopic sc...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Korean Society of Gastrointestinal Endoscopy
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3928493/ https://ncbi.nlm.nih.gov/pubmed/24570884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5946/ce.2014.47.1.55 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|